Atebimetinib
Atebimetinib (IMM-1-104) is an orally active, deeply periodic MEK inhibitor that directly targets MEK and chronically suppresses MAPK signaling. It is intended for combination therapy in metastatic pancreatic cancer and non-small cell lung cancer (NSCLC) .
Product Specifications
CAS Number
2669009-92-9
Field of Research
Signal Transduction
Purity
99.14% (May vary between batches)
Smiles
O=C1OC=2C=C (OC (=O) N (C) C) C=CC2C (=C1CC=3C=CC=C (NS (=O) (=O) NC) C3F) CN (C) C
Molecular Formula
C23H27FN4O6S
Molecular Weight
506.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
